TAMSULOSIN VERSUS TADALAFIL FOR MANAGEMENT OF SYMPTOMATIC BENIGN PROSTATIC ENLARGEMENT: ASSESSMENT OF TREATMENT DISCONTINUATION RATE AND SYMPTOMS IMPROVEMENT

Authors
Category Primary study
JournalJournal of urology
Year 2023
This article has no abstract
Epistemonikos ID: f3520502040bbcde2e4efd11b8ceac78d4f65217
First added on: Feb 16, 2024